Can You Get IV Ketamine at Home? What At-Home Ketamine Treatment Actually Looks Like

If you have been searching for "IV ketamine at home," you are asking a genuinely good question, and you deserve a straight answer instead of a sales pitch. I am a physician who prescribes at-home ketamine therapy, and in this post I will tell you exactly what is and is not possible: why no legitimate program will hand you an IV bag, what mobile in-home infusion and self-injected routes actually offer, and what at-home ketamine treatment really looks like when it is done properly.

Can You Get IV Ketamine at Home?

Not in the way most people searching this phrase imagine. No legitimate medical program prescribes IV ketamine for patients to self-administer at home, because an intravenous infusion requires a trained clinician monitoring you while the drug is running. What does exist is a middle path: in some cities, mobile or concierge IV services will send a nurse to your home to administer the infusion. And for treatment that is genuinely designed for home use, physician-supervised programs prescribe a different route entirely, most often sublingual ketamine.

So the honest answer has several parts: self-administered home IV, no; nurse-administered home IV, sometimes, in some places, at a price; self-injected subcutaneous ketamine, increasingly advertised and evidence-backed but with real caveats; and at-home treatment by the sublingual route, yes, which is what most legitimate programs are built around. The rest of this article unpacks each one.

Why Do Clinics Use IV Ketamine in the First Place?

Clinics use IV because it is the most precise and most studied way to deliver ketamine. An infusion puts 100 percent of the dose directly into your bloodstream, and the drip rate can be adjusted minute by minute.

That precision matters for a few reasons:

• Complete bioavailability. IV delivery is the pharmacologic reference standard, because every milligram reaches circulation. Most of the foundational research on ketamine for depression used IV dosing (classically around 0.5 mg/kg over 40 minutes), so clinics are working inside the best-mapped evidence base. A major international expert synthesis on ketamine and esketamine for treatment-resistant depression (McIntyre et al. 2021, American Journal of Psychiatry) reflects how much of that evidence was built on the IV route.
• Real-time titration. If a patient is having a difficult experience or their blood pressure climbs, the clinician can slow or stop the infusion immediately. No other route offers that control.
• Rapid, predictable peaks. For acute situations, including severe, crisis-level depression, the fast onset of IV dosing is clinically meaningful. In head-to-head research against electroconvulsive therapy, IV ketamine performed comparably for nonpsychotic treatment-resistant depression (Anand et al. 2023, New England Journal of Medicine), which says something about how seriously the IV route is taken at the highest levels of psychiatry.

None of this is marketing spin from the infusion-clinic world. IV ketamine is excellent medicine in the right setting. The question is whether that setting can ever be your living room.

Why Don't Legitimate Programs Offer Self-Administered IV at Home?

Because the same properties that make IV powerful make it inappropriate to self-administer. This is a scope-of-practice and safety issue, not a turf war.

Placing and managing an IV line is a clinical skill. Infiltration, infection risk, and dosing errors are all real with intravenous access. More importantly, the rapid plasma peak of IV ketamine produces the deepest dissociation and the largest transient blood-pressure and heart-rate changes of any route, precisely when you are least able to monitor yourself. A person 10 minutes into an infusion cannot adjust their own drip rate, check their own vitals, or respond to an emergency.

That is why every credible standard for IV ketamine, in clinics, hospitals, and home-infusion settings alike, requires a trained clinician present for the entire session. Any operation offering to ship you IV ketamine to run yourself is operating far outside legitimate medical practice, and I would urge you to walk away.

I want to be clear that this is not a criticism of IV ketamine. It is a statement about where each route belongs. I wrote a full route-by-route breakdown in my guide to IV, IM, subcutaneous, and sublingual ketamine at home if you want the deeper pharmacology.

What About Mobile IV Services That Come to Your Home?

Mobile IV ketamine is real, and it is the closest thing that exists to "IV ketamine at home." In a number of metro areas, concierge infusion services will send a registered nurse or nurse practitioner to your home to administer ketamine under a supervising physician's protocol. You get the IV route, meaning full bioavailability, a clinician present, and vitals monitored, in your own space.

Covered fairly, here is the picture:

The upside. For patients with mobility limitations, severe anxiety about clinical settings, or a strong preference for a familiar environment, mobile IV solves a genuine problem. The clinical monitoring is real, and the setting can make the experience itself more comfortable.

The costs. Expect roughly $400 to $800 or more per infusion, frequently at or above clinic pricing, because you are paying for a clinician's travel time and undivided attention. A typical induction series of six infusions puts the total at $2,400 to $5,000+, before maintenance boosters. Insurance rarely covers it.

The limitations. Availability is patchy, since these services cluster in larger cities and may not exist where you live. Quality varies, so vet the operation: there should be a physician medical director, a real screening evaluation before your first infusion, emergency protocols, and a licensed clinician present for the full session (not a quick drop-in). Scheduling is also less flexible than a treatment you keep at home; you are booking a clinician's house call each time.

Mobile IV is a legitimate option for the right patient. But for most people searching "ketamine at home," it is not actually what they need, and it is several times the cost of the route designed for home use.

What About IM and Subcutaneous Ketamine at Home?

This is the fastest-changing part of the at-home landscape, and it deserves a direct answer, because you have probably seen the ads. Intramuscular (IM) and subcutaneous (SC) ketamine are injected routes that behave somewhere between IV and sublingual, and a growing number of telehealth companies now market self-administered subcutaneous injections you give yourself at home.

Intramuscular (IM) ketamine is injected into a muscle. Its bioavailability is high, in the range of 90 percent, and its onset is fast, close to IV. Because the full dose lands quickly and cannot be slowed once it is in, IM is used almost entirely in supervised clinic settings rather than for self-administration. There is no titrating an injection after the needle comes out.

Subcutaneous (SC) ketamine is injected into the fat layer just under the skin. It is absorbed more gradually than IM or IV, which gives it a somewhat gentler curve, and it has genuinely strong recent evidence for depression. The Ketamine for Adult Depression Study (KADS), a randomized double-blind active-controlled trial, found that a four-week course of repeated subcutaneous ketamine injections was effective and reasonably tolerated for treatment-resistant depression (Loo et al. 2023, British Journal of Psychiatry). That is real, high-quality evidence, and it is why subcutaneous ketamine is a legitimate medical route.

The newer question is whether you should inject it yourself, at home, without a clinician in the room. Several telehealth programs have begun shipping subcutaneous ketamine for patients to self-inject, and the advertising is heavy right now. I want to be fair about it: the route itself is evidence-backed, and for a carefully selected, well-trained patient, self-injection is not inherently reckless. But it raises real considerations that a dissolving tablet does not:

• Needle handling and technique. You are performing a medical procedure on yourself, correctly, in the minutes before you become dissociated. Dose-measurement and injection errors carry more consequence than a tablet held under the tongue.
• No take-backs. Once an injection is in, it cannot be spat out or slowed. A sublingual dose that feels too strong can be removed from the mouth; an injected dose cannot be recalled.
• A more intense, faster experience. The injected peak is steeper than sublingual, which for some patients is exactly why careful screening and a sitter matter more, not less.
• Sterility and sourcing. Injectable medication has to be handled cleanly and should come from a licensed compounding pharmacy with clear instructions, never a gray-market vendor.

My own practice prescribes the sublingual route because, for the large majority of patients, it delivers comparable outcomes with the widest safety margin and the lowest procedural burden at home. That is a clinical judgment, not a knock on injectable ketamine, which has a real place. If you are weighing a self-injection program, ask it the same questions I would: genuine medical screening, a required sitter, pharmacy-grade medication, a physician follow-up cadence, and an honest answer about whether the injected route actually adds anything for you over sublingual. If a program cannot answer those, the route is not the problem, the program is.

What Do At-Home Ketamine Programs Actually Prescribe?

Most legitimate at-home ketamine programs prescribe sublingual ketamine, meaning compounded tablets or troches that dissolve under the tongue, because the sublingual route's pharmacology is what makes home treatment appropriate in the first place.

Sublingual absorption delivers roughly 25 to 30 percent bioavailability, compared with 100 percent for IV. That sounds like a downside until you understand how it is used: prescribers calibrate the milligram dose to the route, so a sublingual dose is intentionally higher than an IV dose to achieve a therapeutically comparable exposure. What the route changes is the shape of the curve, giving a gradual onset over 15 to 30 minutes and a gentler peak rather than the steep spike of an infusion. That slower, softer curve is exactly what makes it reasonable for a screened patient to take at home with proper safeguards, and it is why sublingual has become the most common standard for home-based treatment.

Does the gentler route still work? The evidence says yes. The largest prospective study of at-home ketamine treatment to date followed 1,247 patients receiving sublingual ketamine through a telehealth model and found the treatment safe and effective for moderate to severe anxiety and depression, with the majority of patients improving and very low rates of serious adverse events (Hull et al. 2022, Journal of Affective Disorders). And when researchers compare formulations and routes of ketamine for depression more broadly, the antidepressant effect tracks the molecule and adequate dosing rather than the delivery method alone (Bahji et al. 2021, Journal of Affective Disorders).

I have written a detailed comparison of the clinical outcomes in Is At-Home Ketamine as Effective as Clinic Treatment?. The short version is that for standard depression, anxiety, and PTSD indications, calibrated sublingual dosing produces outcomes comparable to infusion-based care.

How Is At-Home Treatment Kept Safe Without a Nurse in the Room?

The safety architecture of a well-run at-home program is front-loaded: instead of monitoring you through a risky peak, it screens and structures the treatment so the peak is never risky to begin with. Here is what that looks like in a properly supervised program:

• Medical screening before anything is prescribed. Blood pressure, cardiovascular history, psychiatric history (including psychosis and mania screening), current medications, and substance-use history. At-home programs should say "no" to candidates an infusion clinic could say "yes" to, because at home, the screening is the safety net.
• Blood-pressure checks. Patients confirm their blood pressure is in a safe range before dosing, since ketamine transiently raises it.
• A sitter. A sober, responsible adult present in the home during every session. Not optional.
• A prepared setting. Session done seated or reclining, no driving for the rest of the day, nothing scheduled afterward.
• Telehealth supervision. Scheduled physician check-ins, dose adjustments made by the prescriber only, and a clear protocol for reporting side effects between visits.
• Controlled dispensing. Medication shipped from a licensed compounding pharmacy in limited quantities, with accountability for each dose.

I go deeper on exactly what patients should demand from any home program in Medical Supervision Standards for Home Ketamine Therapy. If a program you are evaluating skips screening, does not require a sitter, or has no physician follow-up cadence, that is not an at-home program, that is a shipping operation.

How Do the Costs Compare?

Here is the honest cost picture across the legitimate paths:

Option	Typical cost	What you get
Clinic IV infusion	$400-$800 per infusion; $2,400-$4,800 for a 6-infusion series	100% bioavailability, clinician monitoring, clinical setting
Mobile in-home IV	$400-$800+ per infusion; often above clinic rates	IV route with a nurse in your home; limited availability
Self-injected subcutaneous	Varies by program, typically a monthly telehealth fee	Injected route with randomized-trial support; you administer it yourself between check-ins
At-home sublingual program	Typically a few hundred dollars per month of care	Physician screening and telehealth supervision, calibrated sublingual dosing, multiple sessions per month

The pattern to notice: IV pricing is per session, and a full course requires many sessions. Sublingual and self-injection programs are typically priced per month of comprehensive care, which is why an equivalent treatment period usually costs a fraction of an infusion series. None of these is routinely covered by insurance for depression, though HSA/FSA funds often apply. I break down the numbers, financing options, and what "cost per improvement" really looks like in Ketamine Therapy Cost Without Insurance.

Which Option Is Right for You?

Each route has a legitimate place. As a prescriber, here is how I would sort it:

Clinic or mobile IV is the better fit if you are in an acute, crisis-level state that needs rapid effect and close monitoring; you have cardiovascular or medical complexity that warrants minute-to-minute vital-sign management; you are pursuing a chronic-pain infusion protocol; or you completed an adequate, properly dosed sublingual course without response, since some patients absorb the sublingual route poorly and for them an injected route is the logical next step.

A self-injected subcutaneous program can fit a patient who is comfortable with self-injection, passes a genuine screening, has a sitter, and specifically wants the injected route. Just hold it to the same standard you would hold any medical program, and be honest with yourself about whether the needle adds value over a tablet for your situation.

At-home sublingual is the better fit if you have treatment-resistant depression, anxiety, or PTSD without high-risk medical features; you can pass a genuine medical screening; you have a sober adult who can be present during sessions; you value consistency of treatment over weeks (the at-home model removes the logistics that cause people to abandon infusion series midway); and you want the widest safety margin with the least procedural burden.

None is a fit if you have uncontrolled blood pressure, active psychosis or unstable mania, or a current substance-use disorder involving ketamine. A responsible program screens these out for your protection, not as gatekeeping.

The Bottom Line

You cannot get self-administered IV ketamine at home from any legitimate program, and you should not want to, because the IV route's power is inseparable from its need for clinical monitoring. What you can get is a nurse-administered infusion in your home in some cities at a premium, a self-injected subcutaneous program that is evidence-backed but asks you to perform your own injections, or a physician-supervised sublingual program built specifically for safe home use and backed by the largest at-home treatment dataset published to date.

If you are weighing these options, the right starting point is not choosing a route, it is finding out whether ketamine therapy is medically appropriate for you at all. Our free eligibility check takes a few minutes, is reviewed by a physician, and will give you an honest answer about whether at-home treatment fits your situation. If it does not, I will tell you that too, and point you toward the setting that does.